Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2024

Open Access 22-12-2023 | Hepatic Adenoma | Case Report

Patient with a novel syndrome with multiple benign hepatic lesions and extrahepatic neoplasms

Authors: Silvana Wilken, Tharusan Thevathasan, Can Kamali, Adrien Guillot, Jana Ihlow, Uli Fehrenbach, Magdalena Danyel, Johann Pratschke, Frank Tacke, Felix Krenzien

Published in: Clinical Journal of Gastroenterology | Issue 2/2024

Login to get access

Abstract

Simultaneous occurrence of benign hepatic lesions of different types is a sporadic phenomenon. To the best of our knowledge, we report the first clinical case of a syndrome with simultaneous manifestations of three different entities of benign liver tumors (hepatocellular adenoma, focal nodular hyperplasia and hemangioma) with a novel mutation detected in the liver adenoma and in the presence of a number of further extrahepatic organ neoplasms. Furthermore, we describe for the first time the presence of liver epithelial cells of hepatocytic phenotype expressing cytokeratin 7 (CK7) at the border of the adenoma. These findings may be important for explaining pathogenesis of benign as well as malignant tumors based on genetic and histopathological features.
Literature
1.
go back to reference European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65:386–98. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65:386–98.
2.
go back to reference Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163–70.CrossRefPubMed Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163–70.CrossRefPubMed
3.
go back to reference Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976;294:470–2.CrossRefPubMed Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976;294:470–2.CrossRefPubMed
4.
go back to reference Jeannot E, Mellottee L, Bioulac-Sage P, et al. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes. 2010;59:1836–44.CrossRefPubMedPubMedCentral Jeannot E, Mellottee L, Bioulac-Sage P, et al. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes. 2010;59:1836–44.CrossRefPubMedPubMedCentral
5.
go back to reference Di Carlo I, Urrico GS, Ursino V, et al. Simultaneous occurrence of adenoma, focal nodular hyperplasia, and hemangioma of the liver: Are they derived from a common origin? J Gastroenterol Hepatol. 2003;18:227–30.CrossRefPubMed Di Carlo I, Urrico GS, Ursino V, et al. Simultaneous occurrence of adenoma, focal nodular hyperplasia, and hemangioma of the liver: Are they derived from a common origin? J Gastroenterol Hepatol. 2003;18:227–30.CrossRefPubMed
6.
go back to reference Toshikuni N, Kawaguchi K, Miki H, et al. Focal nodular hyperplasia coexistent with hemangioma and multiple cysts of the liver. J Gastroenterol. 2001;36:206–11.CrossRefPubMed Toshikuni N, Kawaguchi K, Miki H, et al. Focal nodular hyperplasia coexistent with hemangioma and multiple cysts of the liver. J Gastroenterol. 2001;36:206–11.CrossRefPubMed
7.
go back to reference Gaspar-Figueiredo S, Kefleyesus A, Sempoux C, et al. Focal nodular hyperplasia associated with a giant hepatocellular adenoma: A case report and review of literature. World J Hepatol. 2021;13:1450–8.CrossRefPubMedPubMedCentral Gaspar-Figueiredo S, Kefleyesus A, Sempoux C, et al. Focal nodular hyperplasia associated with a giant hepatocellular adenoma: A case report and review of literature. World J Hepatol. 2021;13:1450–8.CrossRefPubMedPubMedCentral
8.
go back to reference Shih A, Lauwers GY, Balabaud C, et al. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA. Am J Surg Pathol. 2015;39:1296–300.CrossRefPubMed Shih A, Lauwers GY, Balabaud C, et al. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA. Am J Surg Pathol. 2015;39:1296–300.CrossRefPubMed
9.
go back to reference Friedman LS, Gang DL, Hedberg SE, et al. Simultaneous occurrence of hepatic adenoma and focal nodular hyperplasia: Report of a case and review of the literature. Hepatology. 1984;4:536–40.CrossRefPubMed Friedman LS, Gang DL, Hedberg SE, et al. Simultaneous occurrence of hepatic adenoma and focal nodular hyperplasia: Report of a case and review of the literature. Hepatology. 1984;4:536–40.CrossRefPubMed
10.
go back to reference Guillot A, Kohlhepp MS, Bruneau A, et al. Deciphering the immune microenvironment on a single archival formalin-fixed paraffin-embedded tissue section by an immediately implementable multiplex fluorescence immunostaining protocol. Cancers (Basel). 2020;12:2449.CrossRefPubMed Guillot A, Kohlhepp MS, Bruneau A, et al. Deciphering the immune microenvironment on a single archival formalin-fixed paraffin-embedded tissue section by an immediately implementable multiplex fluorescence immunostaining protocol. Cancers (Basel). 2020;12:2449.CrossRefPubMed
11.
go back to reference McKnight R, Nassar A, Cohen C, et al. Arginase-1: A novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology. Cancer Cytopathol. 2012;120:223–9.CrossRefPubMed McKnight R, Nassar A, Cohen C, et al. Arginase-1: A novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology. Cancer Cytopathol. 2012;120:223–9.CrossRefPubMed
12.
go back to reference Nassar A, Cohen C, Siddiqui MT. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. Diagn Cytopathol. 2009;37:629–35.CrossRefPubMed Nassar A, Cohen C, Siddiqui MT. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. Diagn Cytopathol. 2009;37:629–35.CrossRefPubMed
13.
go back to reference Köhler S, Gargano M, Matentzoglu N, et al. The human phenotype ontology in 2021. Nucleic Acids Res. 2021;49:D1207–17.CrossRefPubMed Köhler S, Gargano M, Matentzoglu N, et al. The human phenotype ontology in 2021. Nucleic Acids Res. 2021;49:D1207–17.CrossRefPubMed
14.
15.
go back to reference Carpino G, Cardinale V, Folseraas T, et al. Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis. Am J Pathol. 2018;188:627–39.CrossRefPubMed Carpino G, Cardinale V, Folseraas T, et al. Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis. Am J Pathol. 2018;188:627–39.CrossRefPubMed
16.
go back to reference Matsukuma S, Takeo H, Kono T, et al. Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study. Histopathology. 2012;61:857–62.CrossRefPubMed Matsukuma S, Takeo H, Kono T, et al. Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study. Histopathology. 2012;61:857–62.CrossRefPubMed
17.
go back to reference Iwasaki T, Kubota A, Suzuki M, et al. A case of small hepatocellular carcinoma with malignant ductular reaction. Int J Clin Exp Pathol. 2020;13:1073–80.PubMedPubMedCentral Iwasaki T, Kubota A, Suzuki M, et al. A case of small hepatocellular carcinoma with malignant ductular reaction. Int J Clin Exp Pathol. 2020;13:1073–80.PubMedPubMedCentral
18.
go back to reference Libbrecht L, De Vos R, Cassiman D, et al. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol. 2001;25:1388–96.CrossRefPubMed Libbrecht L, De Vos R, Cassiman D, et al. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol. 2001;25:1388–96.CrossRefPubMed
19.
go back to reference Roskams T, De Vos R, Desmet V. ‘Undifferentiated progenitor cells’ in focal nodular hyperplasia of the liver. Histopathology. 1996;28:291–9.CrossRefPubMed Roskams T, De Vos R, Desmet V. ‘Undifferentiated progenitor cells’ in focal nodular hyperplasia of the liver. Histopathology. 1996;28:291–9.CrossRefPubMed
20.
go back to reference Gadd VL, Aleksieva N, Forbes SJ. Epithelial plasticity during liver injury and regeneration. Cell Stem Cell. 2020;27:557–73.CrossRefPubMed Gadd VL, Aleksieva N, Forbes SJ. Epithelial plasticity during liver injury and regeneration. Cell Stem Cell. 2020;27:557–73.CrossRefPubMed
Metadata
Title
Patient with a novel syndrome with multiple benign hepatic lesions and extrahepatic neoplasms
Authors
Silvana Wilken
Tharusan Thevathasan
Can Kamali
Adrien Guillot
Jana Ihlow
Uli Fehrenbach
Magdalena Danyel
Johann Pratschke
Frank Tacke
Felix Krenzien
Publication date
22-12-2023
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2024
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-023-01899-3

Other articles of this Issue 2/2024

Clinical Journal of Gastroenterology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.